NEW YORK (GenomeWeb News) – Qiagen said today that it will supply Swiss life sciences firm Microsynth with molecular cador bovine viral diarrhea assays under a multi-year agreement.
Microsynth is one of a few laboratories that has been accredited by the Swiss government to perform tests for BVD, which is one of the most widespread and costly infectious cattle diseases with 60 percent to 80 percent of cattle exposed to the virus, according to Qiagen. The agreement is part of the Swiss national BVD virus eradication program, in which over a million cows are being screened for identification and containment of the disease.
According to the partners, the cador BVDV assay enables testing of pooled samples and is suited for high-throughput settings. Microsynth expects to process as many as 350,000 samples in three months of the program.
In addition to the agreement with Microsynth, Qiagen will supply the Institute of Veterinary Virology at the University of Bern with the assay, QIAamp sample preparation technologies, and BioRobot Universal automation instrument. The institute is an official BVDV reference lab for Switzerland and partnered with Qiagen during development of the PCR-based cador BVDV assay.